Thursday, May 30, 2013: 7:00 PM-8:30 PM
The NARCOMS Registry: Participation Review 1993-2013
Stacey S Cofield, PhD, University of Alabama at Birmingham;
Amber Salter, MPH, University of Alabama at Birmingham;
Tuula Tyry, PhD, St. Joseph's Hospital and Medical Center;
Gary Cutter, PhD, University of Alabama at Birmingham;
Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
Causes Of Death In Patients With Multiple Sclerosis From a Large US Insurance Database
Michael Corwin, MD, Care-Safe;
Shoshana Reshef, PhD, Bayer HealthCare;
Howard Golub, MD, PhD, Care-Safe;
Gary Cutter, PhD, University of Alabama;
David Kaufman, MD, Boston University;
Dirk Pleimes, MD, Bayer HealthCare;
Douglas Goodin, MD, University of California San Francisco Medical Center
Final Results From The Betaseron® (interferon beta -1b) Pregnancy Registry
Patricia K Coyle, MD, Stony Brook University;
Susan S Roberts, PhD, UNCW College of Health and Human Services;
Angela Scheuerle, MD, Tesserae Genetics;
John M Thorp, MD, University of North Carolina Schools of Medicine and Public Health;
Susan King-Zeller, RN, BSN, BSPH, INC Research LLC;
Jessica D Albano, PhD, MPH, INC Research LLC;
Mark Rametta, DO, Bayer HealthCare
Mortality In Multiple Sclerosis: A Systematic Literature Review and Meta-Analysis
Kyle Fahrbach, PhD, United BioSource Corporation;
Lauren Strand, BA, United BioSource Corporation;
Amber Martin, BS, United BioSource Corporation;
Rachel Huelin, BA, United BioSource Corporation;
Edward Kim, MD, MBA, Novartis Pharmaceuticals Corporation;
Karina Raimundo, BPharm, MS, Novartis Pharmaceuticals Corporation;
Douglas Goodin, MD, University of California San Francisco Medical Center;
Gary Cutter, PhD, University of Alabama at Birmingham
Evaluation of Didox As a Potential Oral Therapy for MS
Howard L Elford, Ph. D., MOLECULES FOR HEALTH, INC.;
Paul J Yannie, M.S., McGuire VA Medical Center;
Martha Joslyn, B.S., McGuire VA Medical Center;
Andrea Marcu, M.D., McGuire VA Medical Center;
Jeff L Dupree, Ph. D., Virginia Commonwealth Univ;
George H DeVries, Ph. D., McGuire VA Medical Center
Interleukin-11 is a Key Mediator of IVIg Therapy in Experimental Multiple Sclerosis
Carlyn A Figueiredo, MSc, Canadian Blood Services;
Paulina Drohomyrecky, PhD, University of Toronto;
Danila Leontyev, PhD, Canadian Blood Services;
Shannon E Dunn, PhD, Canadian Blood Services;
Donald R Branch, PhD, Canadian Blood Services
Pregnancy Data From The BG-12 (Dimethyl Fumarate) Development Program
Ralf Gold, MD, Ruhr University, Bochum, Germany;
J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA;
Eva Havrdova, MD, PhD, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
Amit Bar-Or, MD, FRCPC, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada;
Ludwig Kappos, MD, University Hospital, Basel Neurology, Basel, Switzerland;
Huixing Yuan, PhD, Weston, MA, USA;
Mark Novas, MD, Weston, MA, USA;
Marianne T. Sweetser, MD, PhD, Weston, MA, USA;
Vissia Viglietta, MD, Weston, MA, USA;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
Environmental Risk Factors Associated With Pediatric Neuromyelitis Optica
Sirisha Grandhe, BA, University of California, San Francisco;
Jennifer Graves, MD, PhD, University of California, San Francisco;
Ellen M Mowry, MD, University of California, San Francisco;
Lauren Krupp, MD, Stony Brook University Medical Center;
Tanuja Chitnis, MD, Massachusetts General Hospital;
Eluen A Yeh, MD, Hospital for Sick Children;
Nancy Kuntz, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Jayne Ness, MD, Children's Hospital Alabama;
Jamie C McDonald, BS, Stony Brook University Medical Center;
Anita L Belman, MD, Stony Brook University Medical Center;
Maria Milazzo, NP, Stony Brook University Medical Center;
Mark Gorman, MD, Boston Children's Hospital;
Bianca Weinstock-Guttman, MD, University of Buffalo;
Moses Rodriguez, MD, Mayo Clinic;
Marc Patterson, MD, Mayo Clinic;
Emmanuelle Waubant, MD, PhD, University of California, San Francisco
Ectopic Lymphoid Follicle In a Mouse Experimental Autoimmune Encephalomyelitis Model
Divya Gupta, BS, Washington University School of Medicine in St. Louis;
Enrique Alvarez, MD/PhD, Washington University School of Medicine in St. Louis;
Robert J Mikesell, BS, Washington University School of Medicine in St. Louis;
Wilnelia Medina, BS, Washington University School of Medicine in St. Louis;
Robyn S Klein, MD/PhD, Washington University School of Medicine in St. Louis;
Anne H Cross, MD, Washington University School of Medicine in St. Louis
Ethnicity and Patient Outcomes In The Top MS Study
Thomas Leist, MD, Thomas Jefferson University;
Howard Zwibel, MD, Neuroscience Consultants Comprehensive Multiple Sclerosis Center;
Clyde Markowitz, MD, University of Pennsylvania School of Medicine;
Bruce A Cohen, MD, Northwestern University;
Patricia K Coyle, MD, Stony Brook University;
Mark Tullman, MD, Missouri Baptist Medical Center;
MerriKay Oleen-Burkey, PhD, Teva Pharmaceuticals;
Marc Schwartz, MS, Mednet Solutions
The Orient Express To MS
Lucy E Ruscoe, RGN, Diploma in Multiple Sclerosis, ukmssna;
Deborah McMillan, RGN, ukmssna;
Dawn Brookfield, RGN, diploma in psychotherapy, diploma in counselling, ukmssna;
Susan Duplock, RGN, ukmssna;
Katherine Robbins, RGN, ukmssna;
Sarah Wyatt, RGN, ukmssna;
Lee-Anne Dippenaar, RGN, ukmssna;
Maggie Mepstead-Payne, RGN, RMN, ukmssna;
Ruth Stross, RGN, ENB148. Neuromedical & Neurosurgical nursing, 1997, Foundation intensive care course, 1998, A43 Parkinson’s Disease (PD) Course, 2002, Clinical course for specialists in Multiple Sclerosis, level 3-2005, ukmssna
Clinical Benefits with Aimspro® in Progessive Multiple Sclerosis: Open Label Study
Christopher E Moore, BSc, MBBS, PhD, FRCP, Queen Alexandra Hospital, Portsmouth, UK.;
M Haq, MBBS, Tonbridge and Maidstone NHS Trust;
Syed Haq, MBBS PhD, Daval International Ltd.
Demographic Characteristics and Progression Of PPMS In The CLIMB Study Population
Kesav Raghavan, BS, Brigham and Women's Hospital;
Brian C Healy, PhD, Massachusetts General Hospital;
Robert L Carruthers, MD, Brigham and Women's Hospital;
Mona AlKhawajah, MD, Brigham and Women's Hospital;
Tanuja Chitnis, MD, Brigham and Women's Hospital
Characterization of Clinical Disease Expression of Multiple Sclerosis in Hispanics
Silvia Delgado, MD, University of Miami;
Athena Hadjixenofontos, BS, University of Miami;
Clara P Manrique, MD, University of Miami;
Melissa Ortega, MD, University of Miami;
Ashley H Beecham, MS, University of Miami;
Leticia Tornes, MD, University of Miami;
Margaret A Pericak-Vance, PhD, University of Miami;
Kottil Rammohan, MD, University of Miami;
Jacob L McCauley, PhD, University of Miami
The NARCOMS Registry: Publication Review 1996-2012
Amber Salter, MPH, University of Alabama at Birmingham;
Tuula Tyry, PhD, St. Joseph's Hospital and Medical Center;
Stacey S Cofield, PhD, University of Alabama at Birmingham;
Gary Cutter, PhD, University of Alabama at Birmingham;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic;
Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba
Ancestry Is a Key Determinant Of Vitamin D Status In Children With Demyelination
Lauren Sham, BSc, Hospital for Sick Children, University of Toronto;
Brenda Banwell, MD, Hospital for Sick Children, University of Toronto;
E Ann Yeh, MD, Hospital for Sick Children, University of Toronto;
Heather Hanwell, PhD, Hospital for Sick Children, University of Toronto
Affiliation Profile Of NARCOMS Registry Participants
Tuula Tyry, PhD, St. Joseph's Hospital and Medical Center;
Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba;
Stacey S Cofield, PhD, University of Alabama at Birmingham;
Gary Cutter, PhD, University of Alabama;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic;
Amber Salter, MPH, University of Alabama at Birmingham
![[ Visit Client Website ]](images/banner.gif)